A galectin-3 ligand corrects the impaired function of human CD4 and CD8 tumor-infiltrating lymphocytes and favors tumor rejection in mice

Nathalie Demotte, Grégoire Wieërs, Patrick Van Der Smissen, Muriel Moser, Christopher Schmidt, Kris Thielemans, Jean Luc Squifflet, Birgit Weynand, Javier Carrasco, Christophe Lurquin, Pierre J. Courtoy, Pierre Van Der Bruggen

Research output: Contribution to journalArticlepeer-review

Search results